Cover Image
市場調查報告書

全球血液產業

The Global Blood Industry

出版商 BCC Research 商品編碼 180731
出版日期 內容資訊 英文 293 Pages
訂單完成後即時交付
價格
Back to Top
全球血液產業 The Global Blood Industry
出版日期: 2017年05月11日 內容資訊: 英文 293 Pages
簡介

全球血液產品市場在2015年達到318億美元、2016年達到335億美元規模。預估同市場在2016年至2021年將以4.9%的CAGR (年複合成長率) 推移,於2021年成長至426億美元規模。

本報告研究分析全球血液產業現況和展望,彙整血液產業結構、市場規模推移和預測、各市場區分分析和展望、血液利用模式和動向、相關法規、市場企業和相對市場佔比、目前產品線、新產品□新技術驗證、相關專利動向等情報。

第1章 前言

第2章 摘要重點

第3章 概要

  • 血液產業
  • 業界術語和縮寫
  • 血液產業歷史
  • 血液及其成分
    • 血漿
    • 細胞成分
    • 免疫球蛋白產品
    • 輸血危險性
    • 輸血相關風險
    • 無病毒血液供給的努力
    • 輸血陰性反應
    • 血液/血漿成份風險

第4章 血液管理系統-血液採集□加工□使用

  • 採血
    • 血液機構和血液設施
    • 採血組織
    • 捐血統計
    • 美國統計
    • 歐洲統計
    • 亞太地區統計
    • 供體招募和法規
    • 血液篩檢和評估
    • 從供體採集血液的方法
    • 血漿採集
    • 血型判定及疾病診斷檢測
    • 血液加工
    • 輸血
    • 輸血種類
  • 血液管理問題
    • 可用性問題
    • 無輸血手術
    • 安全性問題:風險管理
    • 輸血死亡人數

第5章 血液商業規範

  • 美國血液事業相關法規

第6章 全球血液和血液產品市場概要

  • 產業推動因子
    • 血漿來源治療的需求
  • 市場摘要
    • 血液價格
    • 輸血程序模式

第7章 血液產業分析

  • 全球全血採集市場
    • 各國努力和改善點
    • 美國血液採集資料
  • 全球原料血漿採集市場
  • 全球血液治療市場
    • 血漿和血漿來源產品
    • 白蛋白□血漿蛋白質餾分(PPF)
    • 凝血因子
    • 免疫球蛋白
    • 免疫球蛋白市場規模
    • 纖維蛋白封閉劑和凝血□
    • 抗凝血□III
  • 全球血液型判定篩檢產品
  • 血液檢測
    • 聚合□連鎖反應(PCR)增幅
    • 核酸增幅檢測(NAT)
    • 免疫測定法
  • 供體血液檢測產品市場規模
  • 血型判定
    • 市場結構和參與企業
    • 市場規模
  • 全球血液加工裝置和相關產品市場
    • 採集用產品
    • 血液和血漿採集用品
    • 血漿和血液採集裝置
    • 市場參與企業
    • 輸血用產品

第8章 血液研發

  • 血液專門研究機構
    • JEROME H. HOLLAND LABORATORY (ARC)
    • NATIONAL BLOOD FOUNDATION (NBF)
  • 幹細胞研究
  • 代用血液
  • 重組開發動向
  • 免疫球蛋白新開發
    • 纖維蛋白封閉劑和黏結劑
    • 阿茲海默症白蛋白和免疫球蛋白靜脈注射治療
    • 臨床醫療機器協助提升血液供給安全性
    • 獸醫血液市場、其他

第9章 技術

  • 傳統餾分法
    • Cohn餾分法
  • 最新餾分法
    • 微流體餾分法
  • 增幅法
    • 聚合□連鎖反應 (PCR)
    • 核酸增幅技術 (NAT)
  • 免疫測定法
    • □免疫分析法
  • 專利分析
  • 專利案例

第10章 FDA核准機構

第11章 企業簡介

附錄:主要資料來源

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC008K

Report Highlights

The global sales of blood products reached $31.8 billion in 2015 and $33.5 billion in 2016. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2016 to 2021, reaching nearly $42.6 billion in 2021.

Report Includes:

  • An overview of the structure and current market size of the global blood industry, including coverage of such segments as blood and plasma collection, blood and plasma processing, blood therapeutic products, plasma therapeutic products, and emerging trends and products
  • Analyses of global market trends, with data from 2013 to 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Analyses concerning blood therapeutics, processing, screening, and collection technologies
  • Evaluation of government and regulatory factors
  • The impact of diseases on the blood industry
  • An assessment of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry

Report Scope

This study encompasses the wide range of products and services that comprise the global blood-industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

Analyst Credentials

Vijay Laxmi has more than 20 years of domain experience. In addition to experience in business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies.

Ms. Laxmi has authored several market research studies in the healthcare domain on the following subjects:

  • Various medical devices markets.
  • High-growth and niche markets in healthcare and life sciences.
  • The home healthcare market.
  • Medical tourism

Table of Contents

Chapter 1 - Introduction

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing This Study
    • Contribution of the Study and Intended Audience
    • Scope and Format
    • Methodology and Information Sources
    • Analyst's Credentials
    • Related BCC Research Reports

Chapter 2 - Summary and Highlights

  • Summary and Highlights
    • Overview
    • Major Findings
      • Major Trends
      • Key Findings

Chapter 3 - Overview

  • Overview
    • The Blood Industry
    • Blood-Industry Terms and Abbreviations
    • History of the Blood Industry
    • Blood and Its Components
      • Plasma
      • Cellular Elements
      • Immunoglobulin Products
      • The Dangers of Transfused Blood
      • Risks Associated with Transfusion
      • Efforts to Create a Virus-Free Blood Supply
      • Negative Reactions from Blood Transfusions
      • Blood/Plasma Component Risks

Chapter 4 - The Blood-Management System: Blood Collection, Processing and Use

  • The Blood-Management System: Blood Collection, Processing and Use
    • Blood Collection
      • Type of Blood Establishments and Blood Facilities
      • Organizations Collecting Blood
      • Blood-Donation Demographics
      • U.S. Demographics
      • European Demographics
      • Asia-Pacific Demographics
      • Donor Recruitment and Regulations
      • Blood-Donation Regulations: Amendments as of 2016
      • Blood Screening and Evaluation
      • Methods for Collecting Blood from a Donor
      • Plasma Collection
      • Blood Typing and Testing for Diseases
      • Blood Processing
      • Blood Transfusions
      • Types of Transfusions
    • Blood Management Issues
      • Availability Issues
      • Bloodless Surgery
      • Safety Issues: Risk Management
      • Blood-Transfusion Fatalities

Chapter 5 - Regulation of the Blood Business

  • Regulation of the Blood Business
    • Regulation of the U.S. Blood Business
      • Statutory Authority of the FDA
      • The Major Regulations and Policy Matters Concerning the U.S. Blood Supply
      • How Regulations are Implemented
      • Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and
      • Blood Components
      • Other Organizations Involved in Blood Regulation
      • Voluntary Regulation by Professional and Trade Associations
      • The E.U. Blood Directive

Chapter 6 - The Global Blood and Blood Products Market Overview

  • The Global Blood and Blood Products Market Overview
    • Driving Forces of the Industry
      • Demand for Plasma Derived Therapeutics
    • Market Summary
      • Pricing of Blood
      • Patterns of Transfusion Procedures

Chapter 7 - Blood Industry Analysis

  • Blood Industry Analysis
    • Global Markets for Whole Blood Collection
      • Local Efforts and Improvements
      • U.S. Blood Collection Data
    • Global Markets for Source Plasma Collections
    • Global Markets for Blood Therapeutics
      • Plasma and Plasma-Derived Products
      • Albumin and Plasma Protein Fraction
      • Clotting Factors
      • Immunoglobulins
      • Immunoglobulin Market Size
      • Fibrin Sealants and Thrombin
      • Antithrombin III
    • Global Markets for Blood Typing and Blood Screening Products
    • Screening Blood
      • Polymerase Chain Reaction Amplification
      • Nucleic Acid Amplification Test
      • Immunoassay
    • Market Size of Blood Testing Products for Donor Screening
    • Blood Typing
      • Market Structure and Participants
      • Market Size of Blood Typing
    • Global Markets for Blood Processing Equipment and Associated Products
      • Collection Products
      • Blood and Plasma Collection Supplies
      • Blood and Plasma Collection Equipment
      • Market Participants
      • Transfusion Products

Chapter 8 - Blood Research and Development

  • Blood Research and Development
    • Dedicated Blood Research Facilities
      • Jerome H. Holland Laboratory (American Red Cross)
      • National Blood Foundation
    • Stem Cell Research
    • Blood Substitutes
    • Recombinant Development Activities
    • New Developments in Immunoglobulins
      • CSL Behring's Commitment to Clotting-Factor Development
      • Baxter Rixubis Clotting-Factor Development
      • Fibrin Sealant and Glue Developments
      • Albumin and Intravenous Immunoglobulin Treatment for Alzheimer's Disease
      • Investigational Device to Help Improve Blood-Supply Safety
      • The Veterinary Blood Market

Chapter 9 - Technology

  • Technology
    • Classic Fractionation Methods
      • Cohn Fractionation
    • Advanced Fractionation Methods
      • Microfluidic Fractionation
    • Amplification Methods
      • Polymerase Chain Reaction
      • Nucleic Acid Amplification Technology
    • Immunoassay
      • Enzyme Immunoassay
    • Patent Analysis
    • Patent Examples
      • Recent Patents

Chapter 10 - FDA-Licensed Blood Establishments

  • FDA-Licensed Blood Establishments
    • Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood
    • Components
      • Labeling Standards
      • Reporting Requirements for Licensed Establishments
      • FDA-Licensed Establishments

Chapter 11 - Company Profiles

  • Company Profiles

Appendix Major Sources of Information

  • Major Sources of Information
    • Companies
    • Global Blood Donation Sources

Lists of Tables and Figures

About BCC Research

  • About BCC Research
  • BCC Library Access
  • BCC Custom Research

List of Tables

  • TABLE 1: Summary Table: Global Sales of Blood Products, Through 2021 ($ Millions)
  • TABLE 2: Timeline of the Blood Industry
  • TABLE 3: Composition of Blood
  • TABLE 4: Plasma Constituents and Their Function
  • TABLE 5: U.S. Analysis of Major Diseases Contracted from Blood Transfusions
  • TABLE 6: CBER-Licensed Screening Tests for HIV (Last Updated March 2014)
  • TABLE 7: CBER-Licensed Screening Tests for Hepatitis B (Last Updated May 2014)
  • TABLE 8: CBER-Licensed Screening Tests for Hepatitis C (Last Updated July 2014)
  • TABLE 9: CBER-Licensed Screening Tests for HTLV-I and HYLV-II (Last Updated December 2014)
  • TABLE 10: CBER-Licensed Screening Tests for CMV (Last Updated September 2007- 2016)
  • TABLE 11: CBER-Licensed Screening Tests for West Nile Virus (Last Updated August 2007)
  • TABLE 12: CBER-Approved Manufacturers for Syphilis Tests (Last Updated July 2014)
  • TABLE 13: CBER-Licensed Screening Tests for Trypanosoma Cruzi (Last Updated December 2006)
  • TABLE 14: CBER-Approved Manufacturers for Chlamydia Screening Tests (Last Updated July 2014)
  • TABLE 15: CBER-Licensed Screening Tests for Gonorrhea (Last updated July 2014)
  • TABLE 16: Blood Establishments and Blood Facilities
  • TABLE 17: FDA-Registered Blood Establishments by U.S. State* and Possession
  • TABLE 18: Global ABO and Rh Blood Type Distribution Across Countries 2015 (Population vs. %)
  • TABLE 19: Global Population Annual Growth by Selected Age Group and Years, Through 2030 (Millions)
  • TABLE 20: Global Population by Selected Country, 2015 and 2020 (Millions)
  • TABLE 21: U.S. Population by Age Group, 2020-2050 (Thousands)
  • TABLE 22: Expected U.S. Life Expectancy at Birth with Projections, by Gender, 2015 and 2020 (Years)
  • TABLE 23: European Population, By Age Group, 2016-2050 (Thousands)
  • TABLE 24: Asia-Pacific Population, By Age Group, 2016-2050 (Thousands)
  • TABLE 25: Global Life Expectancy, 2010-2015
  • TABLE 26: Global Life Expectancy at Birth, by Selected Country, 2013 and 2014 (Years)
  • TABLE 27: Diseases that can be Treated with Plasmapherisis
  • TABLE 28: Red Blood Cells Compatibility
  • TABLE 29: Red Blood Cells Compatibility
  • TABLE 30: FDA Approved Plasma Providers
  • TABLE 31: Distribution of Blood Types in the U.S. (%)
  • TABLE 32: Tests Routinely Performed on Blood Donations
  • TABLE 33: Blood Type Antigen-Antibody Reactions
  • TABLE 34: Processing of Donated Blood
  • TABLE 35: Compatibility of ABO and RH System
  • TABLE 36: Selected Uses of Fresh Frozen Plasma
  • TABLE 37: Usage and Therapeutic Effect
  • TABLE 38: Listing of Blood Products for Therapeutic Use
  • TABLE 39: Bloodless Medicine and Surgery Hospital Directory
  • TABLE 40: Factors to Reduce Risks of Transfusion-Associated Diseases
  • TABLE 41: Transfusion-Related Fatalities by Complication, FY2008-FY2013
  • TABLE 42: Fatalities Not Related to Transfusion or Transfusion Not Ruled Out, FY2008-FY2013
  • TABLE 43: Postdonation “Not Ruled Out” Fatality Reports by Donated Product, FY2008-FY2013
  • TABLE 44: Federal Organizations Responsible for U.S. Blood Safety
  • TABLE 45: FDA Authority in Regulating Blood Banking and Blood Products
  • TABLE 46: Major Areas of Concern for Inspecting Blood Facilities
  • TABLE 47: U.S. Cost of Blood Components, Through 2014 ($)
  • TABLE 48: U.S. Blood Transfusion and Related Services Codes
  • TABLE 49: Extent of Specific Legislation Covering Safety and Quality of Blood Transfusion
  • TABLE 50: Blood Use in India
  • TABLE 51: Donation and Distribution (JRCS 2015)
  • TABLE 52: Consumption of Blood products in Transfusions in Germany, 2015 (Number of Units per 100,000 Inhabitants)
  • TABLE 53: U.S. Blood Collection and Transfusion Data, Through 2021* (Million Units)
  • TABLE 54: Global Plasma Collection and Values, Through 2021 ($ Billions, Millions Ml)
  • TABLE 55: Global Sales of Plasma Therapeutics, *Through 2021 ($ Millions)
  • TABLE 56: Global Market for Plasma Therapeutic Derivatives, by Type, Through 2021 ($ Millions)
  • TABLE 57: Albumin and PPF Products (%)
  • TABLE 58: Global Market for Albumin and Ppf, Through 2021 ($ Millions)
  • TABLE 59: Global Market for Albumin and PPF, by Country, Through 2021 ($ Millions)
  • TABLE 60: Examples of Blood Clotting Factors
  • TABLE 61: Global and U.S. Hemophilia Statistics*
  • TABLE 62: Global Market for Plasma-Derived and Recombinant Clotting Factors, Through 2021 ($ Millions)
  • TABLE 63: Global Market for Plasma-Derived and Recombinant Clotting Factors by Country, Through 2021 ($ Millions)
  • TABLE 64: Base Cost and Range of Some Known Factor VIII Products ($/%)
  • TABLE 65: Approved Factor VIII Products
  • TABLE 66: Global Market Shares of Factor VIII Companies, 2016 (%/$ Millions)
  • TABLE 67: Average Cost and Price Range of Commonly Used Factor IX Concentrates ($/%)
  • TABLE 68: Approved Factor IX Products
  • TABLE 69: Global Market Shares of Factor IX Companies, 2016 (%/$ Millions)
  • TABLE 70: Approved Factor VII Products (Recombinant: Human)
  • TABLE 71: Global Market Shares of Factor VII Companies, 2016 (%/$ Millions)
  • TABLE 72: Approved Factor XIII Products (Source: Recombinant)
  • TABLE 73: Approved Prothrombin Complex Concentrate Products from Human Plasma
  • TABLE 74: Selected Conditions Treated By IVIG
  • TABLE 75: Approved Immunoglobulins
  • TABLE 76: Approved Hyperimmune Immunoglobulins
  • TABLE 77: Global Market for Immunoglobulins, Through 2021 ($ Millions)
  • TABLE 78: Global Market for Immunoglobulins, by Country, Through 2021 ($ Millions)
  • TABLE 79: Global Market Shares of Immunoglobulin Companies, 2016
  • TABLE 80: Approved Fibrin Sealants and Fibrin Products
  • TABLE 81: Global Market for Fibrin Sealants and Thrombin, Through 2021 ($ Millions)
  • TABLE 82: Global Market for Fibrin Sealants and Thrombin, by Country, Through 2021 ($ Millions)
  • TABLE 83: Global Market Shares of Fibrin Sealants and Thrombin Product Companies, 2016 (%/$ Millions)
  • TABLE 84: Approved Antithrombin Products
  • TABLE 85: Global Market for Antithrombin, Through 2021
  • TABLE 86: Global Market for Antithrombin, by Country, Through 2021 ($ Millions)
  • TABLE 87: Global Market for Blood Typing and Blood Screening Products, by Country, Through 2021 ($ Millions)
  • TABLE 88: Global Market for Blood Typing and Blood Screening Products, Through 2021 ($ Millions)
  • TABLE 89: Selected PCR Donor Screening Tests
  • TABLE 90: Selected NAT Donor Screening Tests
  • TABLE 91: Selected Immunoassay Donor Screening Tests
  • TABLE 92: Global Blood Donor Screening Testing Market, by Type of Test, Through 2021 ($ Millions)
  • TABLE 93: Blood Group and Rh Type and Compatible Blood for Transfusion
  • TABLE 94: Global Instruments and Supplies Market for Blood Typing, by Type, Through 2021 ($ Millions)
  • TABLE 95: Global Market for Blood Collection and Blood Processing Equipment and Disposables, by Country, Through 2021 ($ Millions)
  • TABLE 96: Global Market for Blood and Plasma Collection/Transfusion Products, Through 2021 ($ Millions)
  • TABLE 97: Global Market for Blood Collection Products, by Type, Through 2021 ($ Millions)
  • TABLE 98: Global Market for Transfusion Products, by Type, Through 2021 ($ Millions)
  • TABLE 99: NBF Fundraising Results, 2015
  • TABLE 100: Top Fibrin Sealant and Glue Products and Their Development
  • TABLE 101: Clinical Trial: Albumin in Alzheimer's Treatment
  • TABLE 102: Dog and Cat Blood Types and Descriptions
  • TABLE 103: U.S. and Canada Regional Veterinary Blood Banks
  • TABLE 104: Application of NAT Other Than Detection
  • TABLE 105: Abott's Sales History, 2013-2015 ($ Millions)
  • TABLE 106: AstraZeneca's Sales History, 2013-2015 ($ Millions)
  • TABLE 107: Baxter's Sales History, 2013-2015 ($ Millions)
  • TABLE 108: Bayer's Sales History, 2013-2015 ($ Millions)
  • TABLE 109: Bio-Rad's Sales History, 2013-2015 ($ Millions)
  • TABLE 110: CSL Limited's Sales History, 2013-2015 ($ Millions)
  • TABLE 111: Grifol's Sales History, 2013-2015 ($ Millions)
  • TABLE 112: Haemonetics' Sales History, 2013-2015 ($ Millions)
  • TABLE 113: Hologic's Sales History, 2013-2015 ($ Millions)
  • TABLE 114: LFB Group's Sales History, 2013-2015 ($ Millions)
  • TABLE 115: Novo Nordisk's Sales History, 2013-2015 ($ Millions)
  • TABLE 116: Octapharma's Sales History, 2013-2015 ($ Millions)
  • TABLE 117: Pfizer's Sales History, 2013-2015 ($ Millions)
  • TABLE 118: Roche's Sales History, 2013-2015 ($ Millions)
  • TABLE 119: Sanofi's Sales History, 2013-2015 ($ Millions)

List of Figures

  • FIGURE 1: Summary Figure: Global Sales of Blood Products, 2013-2021 ($ Millions)
  • FIGURE 2: U.S. Total Plasma Collection, 2010-2015 (Units)
  • FIGURE 3: Global Population Annual Growth by Selected Age Group and Years, 2010-2030 (Millions)
  • FIGURE 4: U.S. Population by Age Group, 2020-2050 (Thousands)
  • FIGURE 5: U.S. Life Expectancy at Birth by Gender, 2015 and 2020 (Years)
  • FIGURE 6: European Population, By Age Group, 2016-2050 (Thousands)
  • FIGURE 7: Asia-Pacific Population, By Age Group, 2016-2050 (Thousands)
  • FIGURE 8: Global Life Expectancy at Birth, by Selected Country, 2013 and 2014 (Years)
  • FIGURE 9: Plasma Products' Demand, 2010-2016 (Metric Tons)
  • FIGURE 10: Global Demand for Factor VIII, 2010-2016 (Million International Units)
  • FIGURE 11: Variables Influencing the Dynamics of Demand for Blood for Transfusion
  • FIGURE 12: Blood Market Cost and Pricing Analysis
  • FIGURE 13: Increasing Geriatric Population Base in Africa (60 years and older), 2000-2050 (Millions)
  • FIGURE 14: Increasing Geriatric Population Base in Africa (60 years and older), 2000-2050 (Millions)
  • FIGURE 15: Number of Organs Transplanted in China, 2010-2015
  • FIGURE 16: Percent of Voluntary Blood Donors in NACO-supported blood banks, 2006-2016 (%)
  • FIGURE 17: Increasing Geriatric Population (60 years and older) in Europe, 2000-2050 (Millions)
  • FIGURE 18: U.S. Blood Collection and Transfusion Data, 2014-2021 (Million Units)
  • FIGURE 19: Global Market for Plasma Collections, 2015-2021 ($ Billions)
  • FIGURE 20: Global Market for Plasma Therapeutics, *2013-2021 ($ Millions)
  • FIGURE 21: Global Market Shares of Plasma Therapeutic Sales, by Country, 2015 (%)
  • FIGURE 22: Global Market for Plasma Therapeutic Derivatives by Type, 2013-2021 ($ Millions)
  • FIGURE 23: Global Market for Albumin and PPF, 2013-2021 ($ Millions)
  • FIGURE 24: Global Market for Albumin and PPF by Country, 2013-2021 ($ Millions)
  • FIGURE 25: Global Market for Plasma-Derived and Recombinant Clotting Factors, 2013-2021 ($ Millions)
  • FIGURE 26: Global Market Shares of Clotting Factor Sales, by Human and Recombinant Products, (%)
  • FIGURE 27: Global Market for Plasma-Derived and Recombinant Clotting Factors by Country, 2013-($ Millions)
  • FIGURE 28: Global Market Shares of Factor VIII Companies, 2016 (%)
  • FIGURE 29: Global Market Shares of Factor VIII Sales, by Human and Recombinant Products, 2015 (%)
  • FIGURE 30: Global Market Shares of Factor IX Companies, 2016 (%)
  • FIGURE 31: Global Market Shares of Factor IX Sales, by Human and Recombinant Products, 2015 (%)
  • FIGURE 32: Global Market Shares of Factor VII Companies, 2016 (%)
  • FIGURE 33: Global Market for Immunoglobulins, 2013-2021 ($ Millions)
  • FIGURE 34: Global Market for Immunoglobulins, by Country, 2013-2021 ($ Millions)
  • FIGURE 35: Global Market Shares of Immunoglobulin Companies, 2016
  • FIGURE 36: Global Market for Fibrin Sealants and Thrombin, 2013-2021 ($ Millions)
  • FIGURE 37: Global Market for Fibrin Sealants and Thrombin by Country, 2013-2021 ($ Millions)
  • FIGURE 38: Global Market Shares of Fibrin Sealants and Thrombin Product Companies, 2016 (%)
  • FIGURE 39: Global Market for Antithrombin, 2013-2021 ($ Millions)
  • FIGURE 40: Global Market for Antithrombin, by Country, 2013-2021 ($ Millions)
  • FIGURE 41: Global Market for Blood Typing and Blood Screening Products, by Country, 2013-2021 ($ Millions)
  • FIGURE 42: Global Market Shares of Blood Typing and Blood Screening Product Sales, by Country, (%)
  • FIGURE 43: Global Market for Blood Typing and Blood Screening Products, 2013-2021 ($ Millions)
  • FIGURE 44: Global Blood Donor Screening Testing Market, by Type of Test, 2013-2021 ($ Millions)
  • FIGURE 45: Global Instruments and Supplies Market for Blood Typing, by Type, 2013-2021 ($ Millions)
  • FIGURE 46: Global Market for Blood Collection and Blood Processing Equipment and Disposables, by Country, 2013-2021 ($ Millions)
  • FIGURE 47: Global Market Shares of Blood Collection and Blood Processing Equipment and Disposables, by Country, 2015 (%)
  • FIGURE 48: Global Market for Blood and Plasma Collection/Transfusion Products, 2013-2021 ($ Millions)
  • FIGURE 49: Global Market for Collection Products, by Type, 2013-2021 ($ Millions)
  • FIGURE 50: Global Market for Transfusion Products, by Type, 2013-2021 ($ Millions)
  • FIGURE 51: Application Research Content Area Distribution, 2015
  • FIGURE 52: NIH Spending on Stem Cell Research, 2013-2016 ($ Billions)
  • FIGURE 53: Recombinant Development Activities' Current Scenario of New Drugs, 2015 (%)
  • FIGURE 54: The Basic Enzyme Immunoassay Process
  • FIGURE 55: Abott's Sales History, 2013-2015 ($ Millions)
  • FIGURE 56: AstraZeneca's Sales History, 2013-2015 ($ Millions)
  • FIGURE 57: Baxter's Sales History, 2013-2015 ($ Millions)
  • FIGURE 58: Bayer's Sales History, 2013-2015 ($ Millions)
  • FIGURE 59: Bio-Rad's Sales History, 2013-2015 ($ Millions)
  • FIGURE 60: CSL Limited's Sales History, 2013-2015 ($ Millions)
  • FIGURE 61: Grifol's Sales History, 2013-2015 ($ Millions)
  • FIGURE 62: Haemonetics' Sales History, 2013-2015 ($ Millions)
  • FIGURE 63: Hologic's Sales History, 2013-2015 ($ Millions)
  • FIGURE 64: LFB Group's Sales History, 2013-2015 ($ Millions)
  • FIGURE 65: Novo Nordisk's Sales History, 2013-2015 ($ Millions)
  • FIGURE 66: Octapharma's Sales History, 2013-2015 ($ Millions)
  • FIGURE 67: Pfizer's Sales History, 2013-2015 ($ Millions)
  • FIGURE 68: Roche's Sales History, 2013-2015 ($ Millions)
  • FIGURE 69: Sanofi's Sales History, 2013-2015 ($ Millions)
Back to Top